Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endocardial Catheter Ablation Versus Thoracoscopic Ablation in De Novo Persistent Atrial Fibrillation Patients With Enlarged Left Atrium: A Randomized Controlled Trial

NCT07783984 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07783984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07783984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endocardial Catheter Ablation Versus Thoracoscopic Ablation in De Novo Persistent Atrial Fibrillation Patients With Enlarged Left Atrium: A Randomized Controlled Trial
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2024
Completion date
May 1, 2029
Enrollment
194 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, endocardial ablation, thoracoscopic ablation